Moleculin Biotech, Inc. Accelerates Growth with Successful $4.5 Million Direct Offering and Private Placement
Houston-based clinical stage pharmaceutical company, Moleculin Biotech, Inc., recently announced the successful pricing of a registered direct offering and concurrent private placement. The company specializes in a dive...
Dec 21, 2023
• Major Pharmaceutical Preparations Industry
Stock Offering
NASDAQ
